Literature DB >> 24816728

Reconstructive strategies for dermatofibrosarcomas of the face: role of regenerative dermal templates.

Leonardo Sartore1, Erica Dalla Venezia, Alessandro Della Puppa, Alberto Bedogni, Luca Campana, Giorgio Giatsidis.   

Abstract

BACKGROUND: Dermatofibrosarcomas protuberans is a challenging cutaneous tumor from an oncologic and reconstructive surgical point of view. Involvement of functionally and aesthetically sensitive areas, such as facial units, in young patients accounts for more demanding cases. An updated evaluation of most beneficial excisional/reconstructive strategies in these cases is still lacking.
METHODS: We investigated the potential of regenerative dermal templates in staged postoncologic reconstructive management of a young woman affected by a dermatofibrosarcomas protuberans of the forehead involving the frontal bone.
RESULTS: Final result was optimal in terms of cosmetic and functional recovery, obtaining a pliability, softness, and color similar to surrounding healthy skin.
CONCLUSION: In facial dermatofibrosarcomas protuberans, staged reconstruction with regenerative dermal templates provides a conservative yet safe and effective management, achieving optimal aesthetic outcomes. We suggest its adoption as first-line treatment in facial dermatofibrosarcomas protuberans that cannot be repaired by direct suture and in equivalent benign yet challenging cases.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  conservative treatment; dermatofibrosarcoma protuberans; facial tumors; reconstructive strategies; regenerative dermal template

Mesh:

Year:  2014        PMID: 24816728     DOI: 10.1002/hed.23754

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Role of a new acellular dermal matrix in a multistep combined treatment of dermatofibrosarcoma protuberans of the lumbar region: a case report.

Authors:  Fedele Lembo; Liberato Roberto Cecchino; Domenico Parisi; Aurelio Portincasa
Journal:  J Med Case Rep       Date:  2021-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.